In reports of industry-funded studies that compared the ocular hypotensive efficacy of topical prostaglandins, conclusions in the article abstracts differed from the results of the main outcome measure 62 percent of the time.
While it is important to make parents of severely neurologically damaged newborns aware of the difficulty in predicting their child’s survival chances or future disabilities, it is also crucial to inform them of the statistical evidence about outcomes for their child’s condition.